Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1162 | 1084 | 1265 | 1370 | 1656 | 2070 |
Fund Return | 16.21% | 8.44% | 26.46% | 11.05% | 10.61% | 7.55% |
Place in category | 14 | 128 | 20 | 39 | 194 | 120 |
% in Category | 1 | 6 | 1 | 3 | 11 | 9 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
JPMorgan Global Income D div EUR | 16.83B | 1.85 | -1.95 | 1.43 | ||
JPM Global Income A acc EUR | 16.83B | 2.00 | -1.60 | 1.78 | ||
JPMorgan Global Income A Div EUR | 16.83B | 2.00 | -1.60 | 1.78 | ||
LU0740858492 | 16.83B | 1.85 | -1.95 | 1.42 | ||
JPM Global Income Fund A Mth EUR | 16.83B | 2.00 | -1.61 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
European Growth Fund Y Acc EUR | 136.58M | 8.71 | 5.97 | 6.00 | ||
European Growth Fund A DIST Eue | 6.35B | 8.40 | 5.09 | 5.14 | ||
European Growth Fund Y DIST EUR | 63.38M | 8.72 | 5.97 | 6.00 | ||
European Growth Fund A Acc EUR | 176.13M | 8.37 | 5.07 | 5.13 | ||
European Growth Fund E Acc EUR | 21.17M | 8.03 | 4.29 | 4.35 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
JPMorgan Liquidity Funds Euro Liquidity Fund X ( | LU0836346931 | 8.14 | 10,371.160 | +0.01% | |
Novo Nordisk B | DK0062498333 | 4.53 | 987.9 | -0.59% | |
ASML Holding | NL0010273215 | 3.86 | 963.40 | -2.58% | |
Novartis | CH0012005267 | 2.79 | 94.03 | -0.32% | |
Nestle | CH0038863350 | 2.43 | 93.70 | -1.26% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review